Literature DB >> 21988305

Laser vaccine adjuvant for cutaneous immunization.

Xinyuan Chen1, Mei X Wu.   

Abstract

Simple and efficient technologies for intradermal immunization have recently been developed, making cutaneous vaccination a valid alternative for vaccine delivery. This raises an urgent need for safe and potent adjuvants suitable for cutaneous vaccination. Many traditional adjuvants like aluminum-based adjuvants may not be appropriate for boosting cutaneous immunization because they evoke strong and persistent inflammation in the skin that would potentially breach its integrity with serious consequences. Laser vaccine adjuvant is induced by brief illumination of a small area of the skin with a safe, noninvasive laser prior to intradermal injection of the vaccine into the site of illumination. It does not stimulate overt inflammation or reactogenicity in the skin and boosts immune responses via enhancing the motility of antigen-presenting cells. Laser vaccine adjuvant is convenient, safe and ideal for augmentation of cutaneous immunization and has distinct advantages over conventional adjuvants, in particular when encountering vaccine shortages during an unpredictable event.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21988305      PMCID: PMC3250349          DOI: 10.1586/erv.11.112

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  47 in total

Review 1.  New horizons in adjuvants for vaccine development.

Authors:  Steven G Reed; Sylvie Bertholet; Rhea N Coler; Martin Friede
Journal:  Trends Immunol       Date:  2008-12-06       Impact factor: 16.687

2.  Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.

Authors:  Ru-Chien Chi; Michael T Rock; Kathleen M Neuzil
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 3.  Perspectives for preventive and therapeutic HPV vaccines.

Authors:  Ken Lin; Kimberley Doolan; Chien-Fu Hung; T C Wu
Journal:  J Formos Med Assoc       Date:  2010-01       Impact factor: 3.282

4.  Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels.

Authors:  Holger Pflicke; Michael Sixt
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

5.  Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.

Authors:  Pierre Van Damme; Robert Arnou; Froukje Kafeja; Anne Fiquet; Patrick Richard; Stéphane Thomas; Gilles Meghlaoui; Sandrine Isabelle Samson; Emilio Ledesma
Journal:  BMC Infect Dis       Date:  2010-05-26       Impact factor: 3.090

6.  A novel laser vaccine adjuvant increases the motility of antigen presenting cells.

Authors:  Xinyuan Chen; Pilhan Kim; Bill Farinelli; Apostolos Doukas; Seok-Hyun Yun; Jeffrey A Gelfand; Richard R Anderson; Mei X Wu
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

Review 7.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

8.  Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.

Authors:  Katherine A Barraclough; Kathryn J Wiggins; Carmel M Hawley; Carolyn L van Eps; David W Mudge; David W Johnson; Michael Whitby; Sally Carpenter; E Geoffrey Playford
Journal:  Am J Kidney Dis       Date:  2009-05-29       Impact factor: 8.860

9.  Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

Authors:  Philip Bejon; John Lusingu; Ally Olotu; Amanda Leach; Marc Lievens; Johan Vekemans; Salum Mshamu; Trudie Lang; Jayne Gould; Marie-Claude Dubois; Marie-Ange Demoitié; Jean-Francois Stallaert; Preeti Vansadia; Terrell Carter; Patricia Njuguna; Ken O Awuondo; Anangisye Malabeja; Omar Abdul; Samwel Gesase; Neema Mturi; Chris J Drakeley; Barbara Savarese; Tonya Villafana; W Ripley Ballou; Joe Cohen; Eleanor M Riley; Martha M Lemnge; Kevin Marsh; Lorenz von Seidlein
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

10.  Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.

Authors:  Jiri Beran; Arvydas Ambrozaitis; Alvydas Laiskonis; Narseta Mickuviene; Patrick Bacart; Yvan Calozet; Etienne Demanet; Stephane Heijmans; Paul Van Belle; Françoise Weber; Camille Salamand
Journal:  BMC Med       Date:  2009-04-02       Impact factor: 8.775

View more
  14 in total

Review 1.  An update on the use of laser technology in skin vaccination.

Authors:  Xinyuan Chen; Ji Wang; Dilip Shah; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2013-10-16       Impact factor: 5.217

Review 2.  Laser vaccine adjuvants. History, progress, and potential.

Authors:  Satoshi Kashiwagi; Timothy Brauns; Jeffrey Gelfand; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Effective and lesion-free cutaneous influenza vaccination.

Authors:  Ji Wang; Bo Li; Mei X Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

4.  Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease.

Authors:  Patricia P Lopes; George Todorov; Thanh T Pham; Anthony B Nesburn; Elmostafa Bahraoui; Lbachir BenMohamed
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  Micro-fractional epidermal powder delivery for improved skin vaccination.

Authors:  Xinyuan Chen; Garuna Kositratna; Chang Zhou; Dieter Manstein; Mei X Wu
Journal:  J Control Release       Date:  2014-08-15       Impact factor: 9.776

6.  Laser-induced capillary leakage for blood biomarker detection and vaccine delivery via the skin.

Authors:  Jeffrey H Wu; Bo Li; Mei X Wu
Journal:  J Biophotonics       Date:  2016-01-18       Impact factor: 3.207

7.  High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.

Authors:  Xinyuan Chen; Marco Pravetoni; Brijesh Bhayana; Paul R Pentel; Mei X Wu
Journal:  Vaccine       Date:  2012-10-30       Impact factor: 3.641

8.  A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.

Authors:  Jeffrey A Gelfand; Rosalynn M Nazarian; Satoshi Kashiwagi; Timothy Brauns; Brent Martin; Yoshifumi Kimizuka; Skylar Korek; Elliot Botvinick; Kristen Elkins; Logan Thomas; Joseph Locascio; Blair Parry; Kristen M Kelly; Mark C Poznansky
Journal:  FASEB J       Date:  2018-09-07       Impact factor: 5.834

9.  A micro-sterile inflammation array as an adjuvant for influenza vaccines.

Authors:  Ji Wang; Dilip Shah; Xinyuan Chen; R Rox Anderson; Mei X Wu
Journal:  Nat Commun       Date:  2014-07-18       Impact factor: 14.919

Review 10.  Understanding natural herpes simplex virus immunity to inform next-generation vaccine design.

Authors:  Kerrie J Sandgren; Kirstie Bertram; Anthony L Cunningham
Journal:  Clin Transl Immunology       Date:  2016-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.